The US alprazolam powder market is supported by established pharmaceutical manufacturing capabilities and continued demand for alprazolam-based therapies used in the management of anxiety and panic disorders. The market is also influenced by the need for reliable pharmaceutical-grade active ingredients and stringent regulatory controls governing controlled substances. Growing focus on compliant...